These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2500842)
1. Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarction. Tranchesi B; Bellotti G; Chamone DF; Verstraete M Am J Cardiol; 1989 Jul; 64(3):229-32. PubMed ID: 2500842 [No Abstract] [Full Text] [Related]
2. Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction. Bär FW; Meyer J; Vermeer F; Michels R; Charbonnier B; Haerten K; Spiecker M; Macaya C; Hanssen M; Heras M; Boland JP; Morice MC; Dunn FG; Uebis R; Hamm C; Ayzenberg O; Strupp G; Withagen AJ; Klein W; Windeler J; Hopkins G; Barth H; von Fisenne MJ Am J Cardiol; 1997 Mar; 79(6):727-32. PubMed ID: 9070549 [TBL] [Abstract][Full Text] [Related]
3. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction. Collen D; Van de Werf F Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077 [TBL] [Abstract][Full Text] [Related]
4. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease]. Nagao K; Kanmatsuse K Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044 [No Abstract] [Full Text] [Related]
15. Saruplase is a safe and effective thrombolytic agent; observations in 1,698 patients: results of the PASS study. Practical Applications of Saruplase Study. Vermeer F; Bösl I; Meyer J; Bär F; Charbonnier B; Windeler J; Barth H J Thromb Thrombolysis; 1999 Aug; 8(2):143-50. PubMed ID: 10436145 [TBL] [Abstract][Full Text] [Related]
16. New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate. Maksimenko AV; Tischenko EG J Thromb Thrombolysis; 1999 Jun; 7(3):307-12. PubMed ID: 10373713 [TBL] [Abstract][Full Text] [Related]
17. Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents. Collen D; Stump DC; Van de Werf F Am Heart J; 1986 Nov; 112(5):1083-4. PubMed ID: 3096127 [No Abstract] [Full Text] [Related]
18. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy. Collen D Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986 [No Abstract] [Full Text] [Related]
19. Neuroradiologists intervene with new therapy for stroke. Sandrick K Diagn Imaging (San Franc); 1999 Jan; 21(1):19-20. PubMed ID: 11692376 [No Abstract] [Full Text] [Related]
20. Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction. Armstrong VW; Neubauer C; Schütz E; Tebbe U Lancet; 1990 Oct; 336(8722):1077. PubMed ID: 1977059 [No Abstract] [Full Text] [Related] [Next] [New Search]